Aravive, Inc. Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Services Agreements (2)
- Supply Agreements (5)
- Collaboration and License Agreement between Aravive, Inc. and 3D Medicines Inc. dated November 6, 2020 (Filed With SEC on November 10, 2020)
- Indemnification Agreement, dated October 17, 2016, by and between Ruga Corporation and Vinay Shah (Filed With SEC on August 3, 2018)
- Master Manufacturing Services Agreement, dated July 11, 2016, by and between WuXi Biologics (Hong Kong) Limited and Aravive Biologics, Inc (Filed With SEC on August 3, 2018)
- VERSARTIS, INC. $150,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on August 10, 2017)
- Amendment No. 2 (hereinafter the "Amendment No. 2") to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the "Agreement") (Filed With SEC on August 7, 2017)
- BI Contract No. 119898 COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on March 10, 2017)
- Amendment No. 1 (hereinafter the Amendment No. 1) to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the Agreement) (Filed With SEC on March 19, 2014)
- VERSARTIS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on March 6, 2014)
- SERVICES AGREEMENT (Filed With SEC on February 18, 2014)
- Assignment of Agreement A Technology Transfer and Clinical Supply Agreement dated October 23, 2012 (Contract Number: BI: 63790), including all attachments, amendments and... (Filed With SEC on February 18, 2014)
- Amendment No. 1 (hereinafter the Amendment No. 1) to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the Agreement) (Filed With SEC on February 18, 2014)
